Page last updated: 2024-08-24

plerixafor and Bilateral Headache

plerixafor has been researched along with Bilateral Headache in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, S; Calandra, GB; Cao, YJ; Conley, J; Dunaway, SB; Flexner, C; Hendrix, CW; Kallungal, B; Klingman, KL; Lalama, C; MacFarland, RT; Park, JG; Snyder, S; Stone, ND; Tierney, C; Wiggins, IP	1
Bolwell, BJ; Bridger, G; Calandra, G; DiPersio, JF; Jacobsen, E; Maziarz, RT; McCarty, J; Micallef, IN; Nademanee, A; Stiff, PJ	1

Trials

2 trial(s) available for plerixafor and Bilateral Headache

Article	Year
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Area Under Curve; Benzimidazoles; Butylamines; Cohort Studies; Dose-Response Relationship, Drug; Fasting; Half-Life; Headache; Heterocyclic Compounds, 1-Ring; Humans; Leukocytes; Male; Middle Aged; Receptors, CXCR4; Time Factors	2007
Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Oct-01, Volume: 27, Issue:28 Topics: Adult; Aged; Benzylamines; Cyclams; Diarrhea; Double-Blind Method; Female; Granulocyte Colony-Stimulating Factor; Headache; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Infusions, Subcutaneous; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prospective Studies; Transplantation, Autologous; Treatment Outcome; Young Adult	2009

Article

Year

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects.

Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Area Under Curve; Benzimidazoles; Butylamines; Cohort Studies; Dose-Response Relationship, Drug; Fasting; Half-Life; Headache; Heterocyclic Compounds, 1-Ring; Humans; Leukocytes; Male; Middle Aged; Receptors, CXCR4; Time Factors

2007

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Oct-01, Volume: 27, Issue:28

Topics: Adult; Aged; Benzylamines; Cyclams; Diarrhea; Double-Blind Method; Female; Granulocyte Colony-Stimulating Factor; Headache; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Infusions, Subcutaneous; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prospective Studies; Transplantation, Autologous; Treatment Outcome; Young Adult

2009